The CEO of Dexcom, a company which sells a distinctly Apple-looking FDA-approved blood glucose monitoring kit, has teased a collaboration with Apple.
Speaking on CNBC, Kevin Sayer discussed a partnership between the two companies that will let diabetes patients track glucose on their Apple Watch.
“It’s coming,” Sayer said. “And this tool is great for people with diabetes.”
The company will apparently launch a number of upgrades for its G6 diabetes system through 2019 This will include a direct-to-Apple Watch version. While it’s already possible to check information from the Dexcom G6 Transmitter on Apple Watch, it sounds like this version will provide a watchOS native version, possibly with more features.
Upward of 8 million people in the U.S. and Europe are currently on insulin therapy. Tools like those developed by Dexcom promise to help make readings easier to access and more actionable in the process. “I assure you there is plenty of room for us to grow over the long term,” Sayer said.
Apple’s push into mobile health
Exactly how close the partnership with Apple is remains to be seen. Sayer doesn’t give much away, although CNBC casts it as “collaboration.”
Mobile health and wellness features have probably become the most compelling reason to buy an Apple Watch. Rather than the early focus on making it a fashion item, newer Apple Watch innovations have focused on things like ECG readings.
Tim Cook has talked about how he feels that health-related initiatives will ultimately prove to be Apple’s biggest legacy as a company.